These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


956 related items for PubMed ID: 31831555

  • 1. lncRNA THAP9-AS1 Promotes Pancreatic Ductal Adenocarcinoma Growth and Leads to a Poor Clinical Outcome via Sponging miR-484 and Interacting with YAP.
    Li N, Yang G, Luo L, Ling L, Wang X, Shi L, Lan J, Jia X, Zhang Q, Long Z, Liu J, Hu W, He Z, Liu H, Liu W, Zheng G.
    Clin Cancer Res; 2020 Apr 01; 26(7):1736-1748. PubMed ID: 31831555
    [Abstract] [Full Text] [Related]

  • 2. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
    Zhao X, Liu Y, Li Z, Zheng S, Wang Z, Li W, Bi Z, Li L, Jiang Y, Luo Y, Lin Q, Fu Z, Rufu C.
    J Cell Mol Med; 2018 Jan 01; 22(1):655-667. PubMed ID: 28984028
    [Abstract] [Full Text] [Related]

  • 3. LncRNA LUCAT1 contributes to cell proliferation and migration in human pancreatic ductal adenocarcinoma via sponging miR-539.
    Nai Y, Pan C, Hu X, Ma Y.
    Cancer Med; 2020 Jan 01; 9(2):757-767. PubMed ID: 31789465
    [Abstract] [Full Text] [Related]

  • 4. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma.
    Ye Y, Chen J, Zhou Y, Fu Z, Zhou Q, Wang Y, Gao W, Zheng S, Zhao X, Chen T, Chen R.
    J Transl Med; 2015 Apr 30; 13():137. PubMed ID: 25925763
    [Abstract] [Full Text] [Related]

  • 5. LncRNA TP73-AS1 enhances the malignant properties of pancreatic ductal adenocarcinoma by increasing MMP14 expression through miRNA -200a sponging.
    Miao H, Lu J, Guo Y, Qiu H, Zhang Y, Yao X, Li X, Lu Y.
    J Cell Mol Med; 2021 Apr 30; 25(7):3654-3664. PubMed ID: 33683827
    [Abstract] [Full Text] [Related]

  • 6. LncRNA PWAR6 regulates proliferation and migration by epigenetically silencing YAP1 in tumorigenesis of pancreatic ductal adenocarcinoma.
    Huang S, Li Y, Hu J, Li L, Liu Z, Guo H, Jiang B, Chen J, Li J, Xiang X, Deng J, Xiong J.
    J Cell Mol Med; 2021 May 30; 25(9):4275-4286. PubMed ID: 33834618
    [Abstract] [Full Text] [Related]

  • 7. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
    Zhang H, Zhu C, He Z, Chen S, Li L, Sun C.
    J Exp Clin Cancer Res; 2020 Sep 05; 39(1):179. PubMed ID: 32891166
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma.
    Wang H, Yu S, Peng H, Shu Y, Zhang W, Zhu Q, Wu Y, Xu Y, Yan J, Xiang H.
    J Exp Clin Cancer Res; 2020 Oct 14; 39(1):216. PubMed ID: 33054826
    [Abstract] [Full Text] [Related]

  • 9. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q, Wu H.
    J Cell Biochem; 2019 Mar 14; 120(3):3874-3886. PubMed ID: 30474270
    [Abstract] [Full Text] [Related]

  • 10. An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.
    Jiang Y, Feng E, Sun L, Jin W, You Y, Yao Y, Xu Y.
    Biomed Pharmacother; 2017 Nov 14; 95():685-691. PubMed ID: 28886528
    [Abstract] [Full Text] [Related]

  • 11. THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma.
    Cheng J, Ma H, Yan M, Xing W.
    Cell Death Dis; 2021 Apr 14; 12(4):401. PubMed ID: 33854048
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
    Yun Z, Meng F, Li S, Zhang P.
    Aging (Albany NY); 2021 Feb 13; 13(4):6041-6054. PubMed ID: 33581689
    [Abstract] [Full Text] [Related]

  • 14. LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
    Sharma A, Chowdhury S, Mukherjee S, Chowdhury R.
    Biol Cell; 2024 Sep 13; 116(9):e2400034. PubMed ID: 38949568
    [Abstract] [Full Text] [Related]

  • 15. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, Li Z, Jiang D, Kong Y, Li Z, Chen R, Chen C.
    Mol Cancer; 2020 May 06; 19(1):83. PubMed ID: 32375768
    [Abstract] [Full Text] [Related]

  • 16. Positive feedback regulation of lncRNA TPT1-AS1 and ITGB3 promotes cell growth and metastasis in pancreatic cancer.
    Cheng C, Liu D, Liu Z, Li M, Wang Y, Sun B, Kong R, Chen H, Wang G, Li L, Hu J, Li Y, Chen H, Zhao Z, Zhang T, Zhu S, Pan S.
    Cancer Sci; 2022 Sep 06; 113(9):2986-3001. PubMed ID: 35534983
    [Abstract] [Full Text] [Related]

  • 17. LncRNA BCAN-AS1 stabilizes c-Myc via N6-methyladenosine-mediated binding with SNIP1 to promote pancreatic cancer.
    Wu G, Su J, Zeng L, Deng S, Huang X, Ye Y, Li R, Bai R, Zhuang L, Li M, Zhou Q, Zheng Y, Deng J, Zhang S, Chen R, Lin D, Zhang J, Zheng J.
    Cell Death Differ; 2023 Oct 06; 30(10):2213-2230. PubMed ID: 37726400
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W, Zhang Y, Xia S.
    Thorac Cancer; 2020 Mar 06; 11(3):549-560. PubMed ID: 31923353
    [Abstract] [Full Text] [Related]

  • 20. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
    Liu P, Yang H, Zhang J, Peng X, Lu Z, Tong W, Chen J.
    Sci Rep; 2017 Jul 12; 7(1):5186. PubMed ID: 28701723
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 48.